Fresenius Medical Care AG (FME.DE)
39.04 EUR -3.60%
Fresenius Medical Care AG fell 3.60% in the latest session, at 39.04 EUR. By market cap it is number 5 of the 6 health care stocks on the DAX 40 heatmap. Its trailing P/E of 11.8 is below the median of those peers (24.3). The price is 14.9% below its 52-week high.
Key numbers
- Price
- 39.04 EUR
- Day change
- -3.60% (-1.46)
- Market cap
- 10.5B EUR
- P/E (trailing)
- 11.8
- P/E (forward)
- 9.3
- Dividend yield
- 3.69%
- 50-day average
- 39.38
- 200-day average
- 39.68
- 52-week range
- 34.57 – 45.90
- Dividend per share (annual)
- 1.49 EUR
Data as of 3 Nov 2026, 17:37 CET. Market data may be delayed.
Fresenius Medical Care AG over the past year
From daily closing prices. The highest close in the period was 45.67 EUR on 3 Nov 2025, the lowest 34.72 EUR on 5 May 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +4.83% | 0.00% | +19.41% | +1.72% | +0.70% |
| Month | Close (EUR) | Change |
|---|---|---|
| November 2026 | 41.46 | +2.62% |
| October 2026 | 40.40 | +2.10% |
| September 2026 | 39.57 | +0.30% |
| August 2026 | 39.45 | -11.25% |
| July 2026 | 44.45 | +12.25% |
| June 2026 | 39.60 | +6.48% |
| May 2026 | 37.19 | -3.68% |
| April 2026 | 38.61 | +0.10% |
| March 2026 | 38.57 | -2.23% |
| February 2026 | 39.45 | +4.06% |
| January 2026 | 37.91 | -6.99% |
| December 2025 | 40.76 | -1.19% |
Health care peers
Fresenius Medical Care AG is on the DAX 40 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Merck KGaA MRK.DE | -0.57% | 64.8B EUR | 27.4 |
| Bayer Aktiengesellschaft BAYN.DE | +3.64% | 50.9B EUR | — |
| Siemens Healthineers AG SHL.DE | -0.12% | 48.5B EUR | 22.0 |
| Fresenius SE & Co. KGaA FRE.DE | +0.47% | 27.5B EUR | 17.6 |
| Fresenius Medical Care AG FME.DE | -3.60% | 10.5B EUR | 11.8 |
| Qiagen N.V. QIA.DE | +0.04% | 9.3B EUR | 26.6 |
More on FME
Open FME.DE in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.